GLOBEIMMUNE, INC.;THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
发明人:
Donald BELLGRAU,Thomas H. KING
申请号：
US15303434
公开号：
US20170035867A1
申请日:
2015.04.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed are methods of treating individuals with yeast-based immunotherapy who have been preselected as being sensitive to type I interferons, as well as methods for selecting individuals for treatment with yeast-based immunotherapeutic compositions and methods for enhancing or improving an individual's response to yeast-based immunotherapy, based on the individual's sensitivity to type 1 interferons (T1IFNs).
